

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.64810083 |
| 2 | regulation of integrin activation (GO:0033623) | 5.58462458 |
| 3 | negative regulation of granulocyte differentiation (GO:0030853) | 5.58016244 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.31194365 |
| 5 | regulation of macrophage chemotaxis (GO:0010758) | 5.03799971 |
| 6 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.57158908 |
| 7 | microglial cell activation (GO:0001774) | 4.50065646 |
| 8 | mature B cell differentiation involved in immune response (GO:0002313) | 4.44774688 |
| 9 | phagocytosis, engulfment (GO:0006911) | 4.38476339 |
| 10 | positive regulation of antigen processing and presentation (GO:0002579) | 4.33401885 |
| 11 | regulation of mononuclear cell migration (GO:0071675) | 4.30587029 |
| 12 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.27211628 |
| 13 | response to peptidoglycan (GO:0032494) | 4.22280758 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 4.19828601 |
| 15 | positive regulation of prostaglandin secretion (GO:0032308) | 4.10113196 |
| 16 | * lipoxygenase pathway (GO:0019372) | 3.98958446 |
| 17 | cellular response to zinc ion (GO:0071294) | 3.91445183 |
| 18 | membrane invagination (GO:0010324) | 3.87683381 |
| 19 | eosinophil chemotaxis (GO:0048245) | 3.85452768 |
| 20 | granulocyte activation (GO:0036230) | 3.84799780 |
| 21 | neutrophil activation (GO:0042119) | 3.84624891 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.84153792 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.84153792 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.84153792 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 3.84153792 |
| 26 | positive regulation by symbiont of host defense response (GO:0052509) | 3.84153792 |
| 27 | modulation by symbiont of host defense response (GO:0052031) | 3.84153792 |
| 28 | apoptotic cell clearance (GO:0043277) | 3.76259819 |
| 29 | germinal center formation (GO:0002467) | 3.75100813 |
| 30 | positive regulation of T cell chemotaxis (GO:0010820) | 3.72355124 |
| 31 | regulation of T cell chemotaxis (GO:0010819) | 3.72355124 |
| 32 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.70950852 |
| 33 | regulation of antigen processing and presentation (GO:0002577) | 3.70035577 |
| 34 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.69117213 |
| 35 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.68754193 |
| 36 | positive regulation of interferon-alpha production (GO:0032727) | 3.68155892 |
| 37 | macrophage activation (GO:0042116) | 3.67744128 |
| 38 | regulation of prostaglandin secretion (GO:0032306) | 3.67225524 |
| 39 | cellular extravasation (GO:0045123) | 3.66061911 |
| 40 | positive regulation of protein homooligomerization (GO:0032464) | 3.65255188 |
| 41 | regulation of germinal center formation (GO:0002634) | 3.62286119 |
| 42 | negative regulation of interleukin-12 production (GO:0032695) | 3.53698794 |
| 43 | regulation of mast cell activation (GO:0033003) | 3.53114516 |
| 44 | respiratory burst (GO:0045730) | 3.47069567 |
| 45 | positive regulation of cholesterol efflux (GO:0010875) | 3.44472681 |
| 46 | positive regulation of mast cell degranulation (GO:0043306) | 3.44126124 |
| 47 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.44126124 |
| 48 | regulation of interferon-alpha production (GO:0032647) | 3.43441946 |
| 49 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.42521450 |
| 50 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.42319138 |
| 51 | positive regulation of lymphocyte migration (GO:2000403) | 3.41996144 |
| 52 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.41991393 |
| 53 | regulation of monocyte chemotaxis (GO:0090025) | 3.41175147 |
| 54 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.39648110 |
| 55 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.39363339 |
| 56 | lymphocyte chemotaxis (GO:0048247) | 3.38809171 |
| 57 | positive regulation of chemokine secretion (GO:0090197) | 3.38167537 |
| 58 | eosinophil migration (GO:0072677) | 3.34784745 |
| 59 | immunoglobulin mediated immune response (GO:0016064) | 3.34135954 |
| 60 | positive regulation of T cell migration (GO:2000406) | 3.32714525 |
| 61 | response to muramyl dipeptide (GO:0032495) | 3.32212588 |
| 62 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.31448296 |
| 63 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.31164682 |
| 64 | myeloid cell activation involved in immune response (GO:0002275) | 3.28857280 |
| 65 | detection of molecule of bacterial origin (GO:0032490) | 3.27825753 |
| 66 | regulation of apoptotic cell clearance (GO:2000425) | 3.26640340 |
| 67 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.24329491 |
| 68 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.18842018 |
| 69 | regulation of T cell migration (GO:2000404) | 3.18788545 |
| 70 | regulation of leukocyte degranulation (GO:0043300) | 3.16151666 |
| 71 | mature B cell differentiation (GO:0002335) | 3.14366063 |
| 72 | negative regulation of interleukin-6 production (GO:0032715) | 3.12918810 |
| 73 | B cell mediated immunity (GO:0019724) | 3.12246679 |
| 74 | regulation of mast cell degranulation (GO:0043304) | 3.10288345 |
| 75 | positive regulation of mast cell activation (GO:0033005) | 3.08375627 |
| 76 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.06019219 |
| 77 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.05093181 |
| 78 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.04829976 |
| 79 | regulation of T cell tolerance induction (GO:0002664) | 3.04802639 |
| 80 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.04015043 |
| 81 | positive regulation of B cell differentiation (GO:0045579) | 3.03577766 |
| 82 | regulation of cholesterol storage (GO:0010885) | 3.02716799 |
| 83 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.02258391 |
| 84 | regulation of lymphocyte migration (GO:2000401) | 3.01156896 |
| 85 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.97918017 |
| 86 | hyaluronan catabolic process (GO:0030214) | 2.97084924 |
| 87 | keratan sulfate catabolic process (GO:0042340) | 2.96962276 |
| 88 | regulation of tolerance induction (GO:0002643) | 2.96464767 |
| 89 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.96067766 |
| 90 | response to protozoan (GO:0001562) | 2.95982590 |
| 91 | complement activation, alternative pathway (GO:0006957) | 2.95646220 |
| 92 | adaptation of signaling pathway (GO:0023058) | 2.92298085 |
| 93 | embryonic process involved in female pregnancy (GO:0060136) | 2.90883303 |
| 94 | * leukotriene metabolic process (GO:0006691) | 2.90243679 |
| 95 | negative regulation of cell killing (GO:0031342) | 2.88648505 |
| 96 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.88648505 |
| 97 | positive regulation of cholesterol transport (GO:0032376) | 2.87544614 |
| 98 | positive regulation of sterol transport (GO:0032373) | 2.87544614 |
| 99 | myeloid dendritic cell differentiation (GO:0043011) | 2.87409234 |
| 100 | defense response to protozoan (GO:0042832) | 2.86098322 |
| 101 | T-helper cell differentiation (GO:0042093) | 2.84576267 |
| 102 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.84576267 |
| 103 | myeloid dendritic cell activation (GO:0001773) | 2.84420003 |
| 104 | T cell migration (GO:0072678) | 2.83605041 |
| 105 | positive regulation of defense response to virus by host (GO:0002230) | 2.83553531 |
| 106 | mannose metabolic process (GO:0006013) | 2.82823355 |
| 107 | leukocyte degranulation (GO:0043299) | 2.82546922 |
| 108 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.82302176 |
| 109 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.82048137 |
| 110 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.81726992 |
| 111 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.81538486 |
| 112 | positive regulation of protein oligomerization (GO:0032461) | 2.80884082 |
| 113 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.79776659 |
| 114 | myeloid leukocyte activation (GO:0002274) | 2.79556627 |
| 115 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.77817610 |
| 116 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.77092506 |
| 117 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.76774138 |
| 118 | positive thymic T cell selection (GO:0045059) | 2.76181997 |
| 119 | response to lipoprotein particle (GO:0055094) | 2.76161533 |
| 120 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.75904755 |
| 121 | Peyers patch development (GO:0048541) | 2.75493826 |
| 122 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.75493826 |
| 123 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.75344596 |
| 124 | positive regulation of icosanoid secretion (GO:0032305) | 2.75308839 |
| 125 | dendritic cell differentiation (GO:0097028) | 2.74990069 |
| 126 | regulation of hypersensitivity (GO:0002883) | 2.74063202 |
| 127 | positive regulation of leukocyte degranulation (GO:0043302) | 2.73797576 |
| 128 | cytokine secretion (GO:0050663) | 2.73780475 |
| 129 | dendritic cell chemotaxis (GO:0002407) | 2.72889279 |
| 130 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.72490027 |
| 131 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.70468637 |
| 132 | positive regulation of interferon-beta production (GO:0032728) | 2.70214790 |
| 133 | regulation of tumor necrosis factor production (GO:0032680) | 2.70139745 |
| 134 | sleep (GO:0030431) | 2.68557747 |
| 135 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.68386196 |
| 136 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.67776909 |
| 137 | positive regulation of T cell apoptotic process (GO:0070234) | 2.67610891 |
| 138 | lymph node development (GO:0048535) | 2.67348499 |
| 139 | endothelial cell chemotaxis (GO:0035767) | 2.66510997 |
| 140 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.64912585 |
| 141 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.64554572 |
| 142 | mast cell activation (GO:0045576) | 2.64239327 |
| 143 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.64108326 |
| 144 | positive regulation of heat generation (GO:0031652) | 2.62959761 |
| 145 | reactive oxygen species biosynthetic process (GO:1903409) | 2.62438777 |
| 146 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.61959694 |
| 147 | production of molecular mediator of immune response (GO:0002440) | 2.61774733 |
| 148 | positive regulation of interleukin-17 production (GO:0032740) | 2.61760996 |
| 149 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.60338491 |
| 150 | amino sugar catabolic process (GO:0046348) | 2.59096136 |
| 151 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.58730210 |
| 152 | pinocytosis (GO:0006907) | 2.57880057 |
| 153 | regulation of icosanoid secretion (GO:0032303) | 2.57065602 |
| 154 | regulation of gamma-delta T cell activation (GO:0046643) | 2.56437388 |
| 155 | negative regulation of lipid storage (GO:0010888) | 2.55779690 |
| 156 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.55431587 |
| 157 | regulation of activated T cell proliferation (GO:0046006) | 2.53513313 |
| 158 | positive regulation of activated T cell proliferation (GO:0042104) | 2.53304698 |
| 159 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.52988607 |
| 160 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.51208221 |
| 161 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.50096719 |
| 162 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.48385496 |
| 163 | positive regulation of T cell differentiation (GO:0045582) | 2.48381085 |
| 164 | negative regulation of T cell mediated immunity (GO:0002710) | 2.48214232 |
| 165 | response to thyroid hormone (GO:0097066) | 2.45837295 |
| 166 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.45663805 |
| 167 | positive regulation of interleukin-10 production (GO:0032733) | 2.45554559 |
| 168 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.44540553 |
| 169 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.44088070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.02702738 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.84324722 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.72000940 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.10083753 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.93889707 |
| 6 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.64631690 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.16191166 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.03005105 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.96121155 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.91280068 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.74509733 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.58160970 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41568745 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.37249916 |
| 15 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.36458487 |
| 16 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.33597051 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.31782660 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.26341146 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.13345870 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.12272212 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.06950718 |
| 22 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.05984906 |
| 23 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.03900071 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.03001238 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.00563727 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.98369596 |
| 27 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97486560 |
| 28 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.92313798 |
| 29 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.90431062 |
| 30 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.89455889 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.88396978 |
| 32 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.86865074 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.85514182 |
| 34 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.82820047 |
| 35 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69394630 |
| 36 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.66334377 |
| 37 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.64774565 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.64177933 |
| 39 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.63338295 |
| 40 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62205671 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60925580 |
| 42 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58987101 |
| 43 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.55151247 |
| 44 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.55093678 |
| 45 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51803133 |
| 46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.51740947 |
| 47 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.51506965 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48473756 |
| 49 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47847972 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.47646341 |
| 51 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.45705113 |
| 52 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44998991 |
| 53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.44556399 |
| 54 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.44507243 |
| 55 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44067830 |
| 56 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.41866919 |
| 57 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.41712914 |
| 58 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.41382570 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40022506 |
| 60 | * P68_20966046_ChIP-Seq_HELA_Human | 1.38701953 |
| 61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36749992 |
| 62 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.35440319 |
| 63 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.33810239 |
| 64 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33769825 |
| 65 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.32289571 |
| 66 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31709819 |
| 67 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.31636196 |
| 68 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.31636196 |
| 69 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.31636196 |
| 70 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.30518327 |
| 71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29612599 |
| 72 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26980600 |
| 73 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26234808 |
| 74 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.26220599 |
| 75 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.22485619 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21248148 |
| 77 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.20416369 |
| 78 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20226129 |
| 79 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19793662 |
| 80 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19776727 |
| 81 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.19468078 |
| 82 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.18725775 |
| 83 | MYB_26560356_Chip-Seq_TH2_Human | 1.18721342 |
| 84 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18551959 |
| 85 | SA1_27219007_Chip-Seq_Bcells_Human | 1.17750019 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17710444 |
| 87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17151293 |
| 88 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.15970625 |
| 89 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.14352470 |
| 90 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.12427513 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12132506 |
| 92 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.11431683 |
| 93 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10762979 |
| 94 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.10251709 |
| 95 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10064287 |
| 96 | P300_27268052_Chip-Seq_Bcells_Human | 1.09988845 |
| 97 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.08951208 |
| 98 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08804689 |
| 99 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.08313987 |
| 100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08128340 |
| 101 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07690480 |
| 102 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.07125822 |
| 103 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06631546 |
| 104 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05813966 |
| 105 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05719101 |
| 106 | MYB_26560356_Chip-Seq_TH1_Human | 1.04497785 |
| 107 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.04467907 |
| 108 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.03648862 |
| 109 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.03425898 |
| 110 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.98940404 |
| 111 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97566786 |
| 112 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.97385114 |
| 113 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.96803741 |
| 114 | UTX_26944678_Chip-Seq_JUKART_Human | 0.94574491 |
| 115 | MAF_26560356_Chip-Seq_TH2_Human | 0.94511828 |
| 116 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94147310 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93377705 |
| 118 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.93258190 |
| 119 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.92849405 |
| 120 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90463369 |
| 121 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.90176776 |
| 122 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89665938 |
| 123 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88080007 |
| 124 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86486754 |
| 125 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86067265 |
| 126 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85092749 |
| 127 | MYC_22102868_ChIP-Seq_BL_Human | 0.84702979 |
| 128 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.83566255 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80650443 |
| 130 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80609563 |
| 131 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.79727102 |
| 132 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.78526742 |
| 133 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.78215306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.67403425 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.84479616 |
| 3 | MP0003436_decreased_susceptibility_to | 3.48027434 |
| 4 | * MP0002148_abnormal_hypersensitivity_rea | 3.47407857 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 3.35930931 |
| 6 | MP0006082_CNS_inflammation | 2.86707328 |
| 7 | MP0002419_abnormal_innate_immunity | 2.77690177 |
| 8 | MP0000685_abnormal_immune_system | 2.73798206 |
| 9 | MP0003724_increased_susceptibility_to | 2.66897462 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.65004916 |
| 11 | MP0009840_abnormal_foam_cell | 2.58185641 |
| 12 | MP0001790_abnormal_immune_system | 2.57091713 |
| 13 | MP0005387_immune_system_phenotype | 2.57091713 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.38460779 |
| 15 | MP0005025_abnormal_response_to | 2.34965387 |
| 16 | MP0004510_myositis | 2.29910262 |
| 17 | MP0009785_altered_susceptibility_to | 2.29420509 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.29346529 |
| 19 | MP0009278_abnormal_bone_marrow | 2.27093164 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.24689649 |
| 21 | MP0003075_altered_response_to | 2.17872505 |
| 22 | MP0001800_abnormal_humoral_immune | 2.15428615 |
| 23 | MP0002723_abnormal_immune_serum | 2.05166618 |
| 24 | MP0005670_abnormal_white_adipose | 2.03172269 |
| 25 | MP0005671_abnormal_response_to | 2.02186149 |
| 26 | MP0003806_abnormal_nucleotide_metabolis | 1.98081019 |
| 27 | MP0001819_abnormal_immune_cell | 1.88996779 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.88881740 |
| 29 | MP0002420_abnormal_adaptive_immunity | 1.88088144 |
| 30 | * MP0002405_respiratory_system_inflammati | 1.86825034 |
| 31 | MP0002254_reproductive_system_inflammat | 1.84779605 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.83564285 |
| 33 | MP0000343_altered_response_to | 1.74994895 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.68334665 |
| 35 | MP0003828_pulmonary_edema | 1.67168556 |
| 36 | MP0005075_abnormal_melanosome_morpholog | 1.66966522 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.62062707 |
| 38 | MP0002653_abnormal_ependyma_morphology | 1.59543216 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.58303190 |
| 40 | MP0005310_abnormal_salivary_gland | 1.57249387 |
| 41 | MP0003690_abnormal_glial_cell | 1.55498717 |
| 42 | MP0002009_preneoplasia | 1.54795400 |
| 43 | MP0001853_heart_inflammation | 1.54303356 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.53864959 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.53447279 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.53447279 |
| 47 | MP0002006_tumorigenesis | 1.52019694 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.50014397 |
| 49 | MP0003303_peritoneal_inflammation | 1.49136539 |
| 50 | MP0005503_abnormal_tendon_morphology | 1.40984169 |
| 51 | MP0005174_abnormal_tail_pigmentation | 1.40570069 |
| 52 | MP0008469_abnormal_protein_level | 1.39203436 |
| 53 | MP0000716_abnormal_immune_system | 1.39172068 |
| 54 | MP0005171_absent_coat_pigmentation | 1.36184307 |
| 55 | MP0003448_altered_tumor_morphology | 1.32554035 |
| 56 | MP0002139_abnormal_hepatobiliary_system | 1.29375799 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.28203045 |
| 58 | MP0004947_skin_inflammation | 1.26562317 |
| 59 | MP0002398_abnormal_bone_marrow | 1.23215965 |
| 60 | MP0003646_muscle_fatigue | 1.22275733 |
| 61 | MP0004782_abnormal_surfactant_physiolog | 1.14785028 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.14576827 |
| 63 | MP0009764_decreased_sensitivity_to | 1.14103788 |
| 64 | MP0003453_abnormal_keratinocyte_physiol | 1.12628374 |
| 65 | MP0005076_abnormal_cell_differentiation | 1.11407714 |
| 66 | MP0005084_abnormal_gallbladder_morpholo | 1.11109784 |
| 67 | MP0002396_abnormal_hematopoietic_system | 1.11040224 |
| 68 | MP0002429_abnormal_blood_cell | 1.11000717 |
| 69 | MP0000490_abnormal_crypts_of | 1.10074412 |
| 70 | MP0003763_abnormal_thymus_physiology | 1.08348136 |
| 71 | MP0009115_abnormal_fat_cell | 1.08174163 |
| 72 | MP0002722_abnormal_immune_system | 1.07831018 |
| 73 | MP0008004_abnormal_stomach_pH | 1.05703113 |
| 74 | MP0008438_abnormal_cutaneous_collagen | 1.04152405 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 1.02715589 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 1.00377201 |
| 77 | MP0005166_decreased_susceptibility_to | 1.00049131 |
| 78 | MP0001873_stomach_inflammation | 0.99147141 |
| 79 | MP0005666_abnormal_adipose_tissue | 0.98551439 |
| 80 | MP0005390_skeleton_phenotype | 0.97586213 |
| 81 | MP0000015_abnormal_ear_pigmentation | 0.96748716 |
| 82 | MP0010368_abnormal_lymphatic_system | 0.95774774 |
| 83 | MP0001663_abnormal_digestive_system | 0.94487166 |
| 84 | MP0004185_abnormal_adipocyte_glucose | 0.92325827 |
| 85 | MP0001915_intracranial_hemorrhage | 0.90428107 |
| 86 | * MP0000249_abnormal_blood_vessel | 0.89461334 |
| 87 | MP0003879_abnormal_hair_cell | 0.88656123 |
| 88 | MP0001501_abnormal_sleep_pattern | 0.87246104 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 0.87226868 |
| 90 | MP0005379_endocrine/exocrine_gland_phen | 0.86061217 |
| 91 | MP0004883_abnormal_blood_vessel | 0.85328079 |
| 92 | MP0005377_hearing/vestibular/ear_phenot | 0.85235669 |
| 93 | MP0003878_abnormal_ear_physiology | 0.85235669 |
| 94 | MP0003279_aneurysm | 0.85224690 |
| 95 | MP0002971_abnormal_brown_adipose | 0.84898663 |
| 96 | MP0005164_abnormal_response_to | 0.84048947 |
| 97 | MP0004130_abnormal_muscle_cell | 0.83343232 |
| 98 | MP0001348_abnormal_lacrimal_gland | 0.83331060 |
| 99 | MP0004019_abnormal_vitamin_homeostasis | 0.82188723 |
| 100 | MP0000372_irregular_coat_pigmentation | 0.82057013 |
| 101 | MP0003566_abnormal_cell_adhesion | 0.81983762 |
| 102 | MP0000858_altered_metastatic_potential | 0.81946139 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.81179586 |
| 104 | MP0000371_diluted_coat_color | 0.80156544 |
| 105 | MP0005646_abnormal_pituitary_gland | 0.79808149 |
| 106 | MP0009763_increased_sensitivity_to | 0.79693775 |
| 107 | MP0000604_amyloidosis | 0.79662292 |
| 108 | MP0008057_abnormal_DNA_replication | 0.79193544 |
| 109 | MP0003045_fibrosis | 0.75428510 |
| 110 | MP0005334_abnormal_fat_pad | 0.75104449 |
| 111 | MP0002933_joint_inflammation | 0.73462761 |
| 112 | MP0000609_abnormal_liver_physiology | 0.72107165 |
| 113 | MP0005165_increased_susceptibility_to | 0.71388770 |
| 114 | MP0003300_gastrointestinal_ulcer | 0.71374458 |
| 115 | MP0000703_abnormal_thymus_morphology | 0.70069000 |
| 116 | MP0003195_calcinosis | 0.69870965 |
| 117 | MP0003186_abnormal_redox_activity | 0.69055703 |
| 118 | MP0009379_abnormal_foot_pigmentation | 0.68748941 |
| 119 | MP0004742_abnormal_vestibular_system | 0.68323420 |
| 120 | MP0000681_abnormal_thyroid_gland | 0.67459706 |
| 121 | MP0001542_abnormal_bone_strength | 0.66812168 |
| 122 | MP0003638_abnormal_response/metabolism_ | 0.66554256 |
| 123 | MP0005410_abnormal_fertilization | 0.66337633 |
| 124 | MP0005319_abnormal_enzyme/_coenzyme | 0.66168572 |
| 125 | MP0002132_abnormal_respiratory_system | 0.65849888 |
| 126 | MP0001851_eye_inflammation | 0.64785088 |
| 127 | MP0003705_abnormal_hypodermis_morpholog | 0.64781981 |
| 128 | MP0003866_abnormal_defecation | 0.64518843 |
| 129 | MP0004808_abnormal_hematopoietic_stem | 0.64418607 |
| 130 | MP0009384_cardiac_valve_regurgitation | 0.64328576 |
| 131 | MP0002735_abnormal_chemical_nociception | 0.63848931 |
| 132 | MP0000767_abnormal_smooth_muscle | 0.63050623 |
| 133 | MP0003795_abnormal_bone_structure | 0.62479816 |
| 134 | MP0005647_abnormal_sex_gland | 0.59997692 |
| 135 | MP0005083_abnormal_biliary_tract | 0.59732503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 9.19401024 |
| 2 | Glomerulonephritis (HP:0000099) | 6.72360018 |
| 3 | Recurrent abscess formation (HP:0002722) | 6.13153547 |
| 4 | Dysostosis multiplex (HP:0000943) | 5.80247237 |
| 5 | Complement deficiency (HP:0004431) | 5.46341207 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 5.42556566 |
| 7 | Pustule (HP:0200039) | 5.38387007 |
| 8 | Abnormality of complement system (HP:0005339) | 5.29392068 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.83178897 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 4.68407516 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.36467640 |
| 12 | Mucopolysacchariduria (HP:0008155) | 4.34362452 |
| 13 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.34362452 |
| 14 | Axonal loss (HP:0003447) | 4.26772750 |
| 15 | Nephritis (HP:0000123) | 4.22627584 |
| 16 | Stomatitis (HP:0010280) | 4.02863642 |
| 17 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.02765427 |
| 18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.02765427 |
| 19 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.02765427 |
| 20 | Increased IgM level (HP:0003496) | 3.86623695 |
| 21 | Abnormality of macrophages (HP:0004311) | 3.57172683 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.55382318 |
| 23 | Increased cerebral lipofuscin (HP:0011813) | 3.43560965 |
| 24 | Thick nail (HP:0001805) | 3.30580056 |
| 25 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.20342584 |
| 26 | Myositis (HP:0100614) | 3.19636401 |
| 27 | Abnormality of glycolipid metabolism (HP:0010969) | 3.14379893 |
| 28 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.14379893 |
| 29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.14379893 |
| 30 | Recurrent fungal infections (HP:0002841) | 3.14045269 |
| 31 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.11941192 |
| 32 | Cerebral aneurysm (HP:0004944) | 3.07565399 |
| 33 | Asymmetric septal hypertrophy (HP:0001670) | 3.05793781 |
| 34 | Orchitis (HP:0100796) | 3.04728548 |
| 35 | Disinhibition (HP:0000734) | 3.01723499 |
| 36 | Recurrent skin infections (HP:0001581) | 3.01263705 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 2.96521384 |
| 38 | Autoimmune thrombocytopenia (HP:0001973) | 2.95610178 |
| 39 | Gingivitis (HP:0000230) | 2.91380571 |
| 40 | Increased serum ferritin (HP:0003281) | 2.86889558 |
| 41 | Keratoconjunctivitis sicca (HP:0001097) | 2.84955798 |
| 42 | Amyloidosis (HP:0011034) | 2.80605902 |
| 43 | Keratoconjunctivitis (HP:0001096) | 2.77588425 |
| 44 | Agnosia (HP:0010524) | 2.77257878 |
| 45 | Colitis (HP:0002583) | 2.76214961 |
| 46 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.73587084 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.70674619 |
| 48 | Myocardial infarction (HP:0001658) | 2.69750634 |
| 49 | Joint stiffness (HP:0001387) | 2.69142364 |
| 50 | Mutism (HP:0002300) | 2.66733832 |
| 51 | IgG deficiency (HP:0004315) | 2.58535813 |
| 52 | Prolonged bleeding time (HP:0003010) | 2.54240053 |
| 53 | Hematochezia (HP:0002573) | 2.51486231 |
| 54 | Periodontitis (HP:0000704) | 2.48671091 |
| 55 | Optic neuritis (HP:0100653) | 2.44988667 |
| 56 | Retrobulbar optic neuritis (HP:0100654) | 2.44988667 |
| 57 | Eosinophilia (HP:0001880) | 2.42619669 |
| 58 | Upper motor neuron abnormality (HP:0002127) | 2.39430282 |
| 59 | Abolished electroretinogram (ERG) (HP:0000550) | 2.39041211 |
| 60 | Abnormality of iron homeostasis (HP:0011031) | 2.39002728 |
| 61 | Prostate neoplasm (HP:0100787) | 2.38610195 |
| 62 | Obstructive lung disease (HP:0006536) | 2.38302512 |
| 63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.38302512 |
| 64 | Rectovaginal fistula (HP:0000143) | 2.36289476 |
| 65 | Rectal fistula (HP:0100590) | 2.36289476 |
| 66 | Recurrent viral infections (HP:0004429) | 2.35571210 |
| 67 | Cellulitis (HP:0100658) | 2.34892031 |
| 68 | Purpura (HP:0000979) | 2.34345054 |
| 69 | Progressive neurologic deterioration (HP:0002344) | 2.31315703 |
| 70 | Petechiae (HP:0000967) | 2.31049266 |
| 71 | Abnormality of the prostate (HP:0008775) | 2.30166405 |
| 72 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.27507067 |
| 73 | Beaking of vertebral bodies (HP:0004568) | 2.24991708 |
| 74 | Inflammation of the large intestine (HP:0002037) | 2.24270090 |
| 75 | Leukocytosis (HP:0001974) | 2.23595691 |
| 76 | Severe combined immunodeficiency (HP:0004430) | 2.23369214 |
| 77 | Vertigo (HP:0002321) | 2.22747734 |
| 78 | Intestinal fistula (HP:0100819) | 2.21576772 |
| 79 | Combined immunodeficiency (HP:0005387) | 2.20394125 |
| 80 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.19028498 |
| 81 | Recurrent cutaneous fungal infections (HP:0011370) | 2.19028498 |
| 82 | Hemoptysis (HP:0002105) | 2.16726160 |
| 83 | Osteolytic defects of the hand bones (HP:0009699) | 2.16455995 |
| 84 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.16455995 |
| 85 | Abnormality of T cell number (HP:0011839) | 2.15593913 |
| 86 | T lymphocytopenia (HP:0005403) | 2.15432831 |
| 87 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.15426141 |
| 88 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.11254220 |
| 89 | Hypergammaglobulinemia (HP:0010702) | 2.10961074 |
| 90 | Vaginal fistula (HP:0004320) | 2.10329685 |
| 91 | Pathologic fracture (HP:0002756) | 2.08981693 |
| 92 | Spondylolisthesis (HP:0003302) | 2.08871382 |
| 93 | Encephalitis (HP:0002383) | 2.08871008 |
| 94 | Abnormality of the pleura (HP:0002103) | 2.08645915 |
| 95 | Decreased central vision (HP:0007663) | 2.05989545 |
| 96 | Abnormality of T cells (HP:0002843) | 2.05897410 |
| 97 | Arterial thrombosis (HP:0004420) | 2.05430938 |
| 98 | Gastrointestinal infarctions (HP:0005244) | 2.05360972 |
| 99 | Pulmonary fibrosis (HP:0002206) | 2.02509297 |
| 100 | Attenuation of retinal blood vessels (HP:0007843) | 2.02145891 |
| 101 | Albinism (HP:0001022) | 2.01466691 |
| 102 | Abnormality of male internal genitalia (HP:0000022) | 1.99559386 |
| 103 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.99458452 |
| 104 | Loss of speech (HP:0002371) | 1.99301150 |
| 105 | Chest pain (HP:0100749) | 1.99294340 |
| 106 | Panhypogammaglobulinemia (HP:0003139) | 1.98988813 |
| 107 | Granulocytopenia (HP:0001913) | 1.98306375 |
| 108 | Gastrointestinal inflammation (HP:0004386) | 1.96775448 |
| 109 | Coarse hair (HP:0002208) | 1.96396267 |
| 110 | Peripheral demyelination (HP:0011096) | 1.95981424 |
| 111 | Hypertensive crisis (HP:0100735) | 1.94413633 |
| 112 | Basal ganglia calcification (HP:0002135) | 1.93050980 |
| 113 | Chronic otitis media (HP:0000389) | 1.92828758 |
| 114 | Neurofibrillary tangles (HP:0002185) | 1.92548806 |
| 115 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89985165 |
| 116 | Epistaxis (HP:0000421) | 1.89145058 |
| 117 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.88753665 |
| 118 | Arthralgia (HP:0002829) | 1.88594335 |
| 119 | Meningitis (HP:0001287) | 1.88397567 |
| 120 | Arterial tortuosity (HP:0005116) | 1.88313752 |
| 121 | Progressive visual loss (HP:0000529) | 1.88265441 |
| 122 | Anhidrosis (HP:0000970) | 1.88132265 |
| 123 | Pulmonary infiltrates (HP:0002113) | 1.86791867 |
| 124 | Nasal polyposis (HP:0100582) | 1.86147433 |
| 125 | Recurrent sinusitis (HP:0011108) | 1.85883698 |
| 126 | Pulmonary embolism (HP:0002204) | 1.85146523 |
| 127 | Hepatosplenomegaly (HP:0001433) | 1.85096498 |
| 128 | Abnormality of eosinophils (HP:0001879) | 1.84990627 |
| 129 | Spinal muscular atrophy (HP:0007269) | 1.84859475 |
| 130 | Urethral obstruction (HP:0000796) | 1.84619482 |
| 131 | Abnormality of T cell physiology (HP:0011840) | 1.84306900 |
| 132 | J-shaped sella turcica (HP:0002680) | 1.83941864 |
| 133 | Abnormality of the peritoneum (HP:0002585) | 1.83665431 |
| 134 | Gangrene (HP:0100758) | 1.83314363 |
| 135 | Clumsiness (HP:0002312) | 1.82757242 |
| 136 | Tongue fasciculations (HP:0001308) | 1.81310812 |
| 137 | Vasculitis (HP:0002633) | 1.80438884 |
| 138 | Urticaria (HP:0001025) | 1.80345327 |
| 139 | IgA deficiency (HP:0002720) | 1.80279887 |
| 140 | Recurrent lower respiratory tract infections (HP:0002783) | 1.80146456 |
| 141 | Abnormality of the nasal mucosa (HP:0000433) | 1.79284840 |
| 142 | Orthostatic hypotension (HP:0001278) | 1.79012694 |
| 143 | Retinal atrophy (HP:0001105) | 1.77872871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.61276357 |
| 2 | TGFBR2 | 4.30203872 |
| 3 | BCKDK | 3.23926599 |
| 4 | MAPK15 | 3.22853155 |
| 5 | NME2 | 3.22114653 |
| 6 | IRAK4 | 3.01175717 |
| 7 | MAP3K14 | 2.73290723 |
| 8 | GRK7 | 2.62590762 |
| 9 | IRAK3 | 2.60999640 |
| 10 | TYK2 | 2.58257265 |
| 11 | MAP4K1 | 2.30140714 |
| 12 | PIM2 | 2.26535957 |
| 13 | TBK1 | 2.23022729 |
| 14 | MAP3K6 | 2.22794388 |
| 15 | MATK | 2.19707153 |
| 16 | GRK6 | 2.16858060 |
| 17 | FGR | 2.16059369 |
| 18 | CSF1R | 2.07067391 |
| 19 | IKBKB | 2.02881580 |
| 20 | CSK | 2.02742771 |
| 21 | CAMK1D | 1.94873190 |
| 22 | BMX | 1.90153556 |
| 23 | MAP3K11 | 1.84775921 |
| 24 | ICK | 1.79966035 |
| 25 | NEK9 | 1.76774727 |
| 26 | TNK2 | 1.69146596 |
| 27 | ERN1 | 1.68500637 |
| 28 | KDR | 1.68217255 |
| 29 | TLK1 | 1.67858002 |
| 30 | STK10 | 1.58664037 |
| 31 | TIE1 | 1.56775333 |
| 32 | RIPK4 | 1.56041979 |
| 33 | MST1R | 1.52090015 |
| 34 | TESK2 | 1.35174354 |
| 35 | MOS | 1.30807684 |
| 36 | MAP4K2 | 1.29189942 |
| 37 | MAP3K13 | 1.26373592 |
| 38 | YES1 | 1.24693887 |
| 39 | CDK6 | 1.23470162 |
| 40 | MAP3K10 | 1.22884719 |
| 41 | TAOK2 | 1.21725425 |
| 42 | DDR2 | 1.20986025 |
| 43 | DAPK1 | 1.19589057 |
| 44 | KIT | 1.19297807 |
| 45 | PIM1 | 1.17304463 |
| 46 | JAK2 | 1.14726389 |
| 47 | BTK | 1.12677911 |
| 48 | JAK1 | 1.12104724 |
| 49 | TEC | 1.11622621 |
| 50 | LYN | 1.10889115 |
| 51 | JAK3 | 1.09464052 |
| 52 | IKBKE | 1.09212181 |
| 53 | CHUK | 1.06773950 |
| 54 | RPS6KL1 | 1.06124551 |
| 55 | RPS6KC1 | 1.06124551 |
| 56 | ZAK | 1.05587374 |
| 57 | TRPM7 | 1.04485024 |
| 58 | RPS6KA6 | 1.03841492 |
| 59 | CAMK1G | 0.98718255 |
| 60 | TAOK3 | 0.98160644 |
| 61 | EPHB1 | 0.97274169 |
| 62 | VRK2 | 0.96348444 |
| 63 | TAOK1 | 0.93501199 |
| 64 | PDK2 | 0.89298460 |
| 65 | TRIB3 | 0.88579063 |
| 66 | HCK | 0.88168957 |
| 67 | CLK1 | 0.87570667 |
| 68 | SYK | 0.86881806 |
| 69 | LCK | 0.86649176 |
| 70 | MUSK | 0.86110941 |
| 71 | MARK3 | 0.85721857 |
| 72 | MAPKAPK3 | 0.82760950 |
| 73 | BMPR2 | 0.79244307 |
| 74 | TXK | 0.77816607 |
| 75 | MAPKAPK2 | 0.77601785 |
| 76 | DYRK1B | 0.75150898 |
| 77 | MET | 0.74545383 |
| 78 | MAPK11 | 0.73807787 |
| 79 | PINK1 | 0.72906514 |
| 80 | PIK3CG | 0.72756633 |
| 81 | ZAP70 | 0.69956906 |
| 82 | PRKCQ | 0.67569663 |
| 83 | GSK3A | 0.65822656 |
| 84 | IRAK2 | 0.65737010 |
| 85 | EIF2AK2 | 0.65001169 |
| 86 | FLT3 | 0.64866176 |
| 87 | ADRBK2 | 0.64756807 |
| 88 | CDK4 | 0.63597347 |
| 89 | PRKAA2 | 0.61744570 |
| 90 | MAPK12 | 0.60874473 |
| 91 | TGFBR1 | 0.58621350 |
| 92 | PAK4 | 0.57819979 |
| 93 | EGFR | 0.57625411 |
| 94 | PKN1 | 0.57515988 |
| 95 | PRKD2 | 0.56980684 |
| 96 | GRK5 | 0.56977794 |
| 97 | PRKCD | 0.54677786 |
| 98 | MAPK4 | 0.53986464 |
| 99 | PTK6 | 0.50964817 |
| 100 | RAF1 | 0.50734919 |
| 101 | GRK1 | 0.50668055 |
| 102 | CAMKK2 | 0.47994438 |
| 103 | PRPF4B | 0.44994148 |
| 104 | MAP3K3 | 0.43035521 |
| 105 | MAPKAPK5 | 0.42933768 |
| 106 | FES | 0.42409329 |
| 107 | IRAK1 | 0.41715560 |
| 108 | MAP2K6 | 0.40944212 |
| 109 | MAP3K1 | 0.37736341 |
| 110 | ARAF | 0.37187688 |
| 111 | ABL2 | 0.36845143 |
| 112 | ABL1 | 0.36475700 |
| 113 | TESK1 | 0.35235585 |
| 114 | MAP2K3 | 0.34614154 |
| 115 | ADRBK1 | 0.33761699 |
| 116 | IGF1R | 0.33582388 |
| 117 | TRIM28 | 0.33507496 |
| 118 | RPS6KA1 | 0.32984954 |
| 119 | STK3 | 0.32708666 |
| 120 | INSR | 0.31725154 |
| 121 | STK16 | 0.31671415 |
| 122 | DAPK2 | 0.30246379 |
| 123 | MAPK7 | 0.29801589 |
| 124 | BMPR1B | 0.29544519 |
| 125 | MAP2K2 | 0.29060153 |
| 126 | HIPK2 | 0.29055155 |
| 127 | DAPK3 | 0.28898137 |
| 128 | RPS6KA5 | 0.27604384 |
| 129 | RIPK1 | 0.26663168 |
| 130 | ITK | 0.26620565 |
| 131 | CDK9 | 0.26217336 |
| 132 | MAPK3 | 0.25209071 |
| 133 | CAMKK1 | 0.22669804 |
| 134 | RPS6KA2 | 0.22104043 |
| 135 | PDK1 | 0.21794671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.74572930 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.84671108 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.58605846 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 2.78862423 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.69856195 |
| 6 | Pertussis_Homo sapiens_hsa05133 | 2.63300334 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.20012795 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.11795904 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.04165224 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.94921672 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.80370707 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.79443734 |
| 13 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.75765939 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.71043678 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.69630239 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.67543110 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.66769421 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.63217260 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.61630312 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.52615609 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.48934785 |
| 22 | Prion diseases_Homo sapiens_hsa05020 | 1.47464558 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.45078718 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44731967 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43941945 |
| 26 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.40660959 |
| 27 | Salmonella infection_Homo sapiens_hsa05132 | 1.39205900 |
| 28 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.35530418 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.33556309 |
| 30 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.32152555 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.30468759 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.28201200 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.27757888 |
| 34 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.24500023 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.23262648 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.20793913 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.17445167 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16976318 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.16533360 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.15779303 |
| 41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.15080720 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14211382 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.11050604 |
| 44 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.10607179 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.08590229 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 1.08177268 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02781553 |
| 48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.01193133 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.00205703 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00163321 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97841601 |
| 52 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.95861610 |
| 53 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.94762078 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.93842905 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91629493 |
| 56 | Histidine metabolism_Homo sapiens_hsa00340 | 0.90735628 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.88700995 |
| 58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.86303180 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 0.84947058 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84921076 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84165476 |
| 62 | Phototransduction_Homo sapiens_hsa04744 | 0.82140358 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80685618 |
| 64 | Asthma_Homo sapiens_hsa05310 | 0.80429754 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79550622 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78961768 |
| 67 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.76726375 |
| 68 | Hepatitis B_Homo sapiens_hsa05161 | 0.76660363 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76296405 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74568434 |
| 71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.73670024 |
| 72 | Base excision repair_Homo sapiens_hsa03410 | 0.73276593 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73105898 |
| 74 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73029149 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.71091864 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.69498134 |
| 77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65691706 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63293508 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63071893 |
| 80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61475840 |
| 81 | Adherens junction_Homo sapiens_hsa04520 | 0.57671939 |
| 82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55404667 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54749642 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54423393 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54182554 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52429856 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.52226635 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.51919159 |
| 89 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51459101 |
| 90 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49592125 |
| 91 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49544383 |
| 92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48747551 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46137822 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45053520 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | 0.44555457 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44041549 |
| 97 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43911292 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43474280 |
| 99 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43003734 |
| 100 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.42799326 |
| 101 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.40557656 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39187180 |
| 103 | Ribosome_Homo sapiens_hsa03010 | 0.38499791 |
| 104 | Olfactory transduction_Homo sapiens_hsa04740 | 0.37333680 |
| 105 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.36152611 |
| 106 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.34660108 |
| 107 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34259818 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34053237 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.33842596 |
| 110 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.33612682 |
| 111 | Homologous recombination_Homo sapiens_hsa03440 | 0.31785232 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31520337 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31058900 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30443358 |
| 115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29727285 |
| 116 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.29234398 |
| 117 | Retinol metabolism_Homo sapiens_hsa00830 | 0.28830006 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.28257756 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28084141 |
| 120 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.27509387 |
| 121 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.25764519 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24488286 |
| 123 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.24397826 |
| 124 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.24303494 |
| 125 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.23812086 |
| 126 | Mineral absorption_Homo sapiens_hsa04978 | 0.23591567 |
| 127 | Pathways in cancer_Homo sapiens_hsa05200 | 0.22332541 |
| 128 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.21962669 |
| 129 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.21332887 |
| 130 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.20975043 |
| 131 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.20777981 |
| 132 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.20654216 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20566568 |
| 134 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.20399402 |

